Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma

Cancer

Volumn 79, Issue 12, 1997, Pages 2435-2439

  Ortega, Jorge A ^a,b   Donaldson, Sarah S ^c   Ivy, S Percy ^d   Pappo, Alberto ^e   Maurer, Harold M ^f  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cyclophosphamide; Rhabdomyosarcoma; VAC chemotherapy; Venoocclusive disease

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; VINCRISTINE;

ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HUMAN; INCIDENCE; LIVER VENOOCCLUSIVE DISEASE; MALE; PRIORITY JOURNAL; RECURRENT CANCER; RECURRENT DISEASE; RHABDOMYOSARCOMA; RISK ASSESSMENT;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DACTINOMYCIN; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INFANT; MALE; RHABDOMYOSARCOMA; VINCRISTINE;

EID: 0030967486     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970615)79:12<2435::AID-CNCR21>3.0.CO;2-R     Document Type: Article

References (21)

1. Shulman HM, McDonald GB, Matthews D, Doney KC, Kopecky KJ, Gaurreau JM, et al. An analysis of hepatic venoocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 1980;79:1178-91.
2. Shulman HM, McDonald GB. Liver disease after marrow transplantation. In: Sale GB, Shulman HM, editors. The pathology of bone marrow transplantation. New York: Mason; 1984: p 104.
3. McDonald GB. Venocclusive disease of the liver following marrow transplantation: marrow transplantation reviews. Issues Hematol/Oncol Immunol 1994;3:49-56.
4. Jacobs P, Miller JL, Uys CJ, Dietrich BE. Fatal veno-occlusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukemia. S Afr Med J 1979;55:5-10.
5. Woods WG, Dehner LP, Nesbit ME. Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation. Am J Med 1980;68:285-90.
6. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995;85:3005-20.
7. Ozkayniak MF, Weinberg K, Kohn D, Sender L, Parckman R, Lenarsky C. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991;7:467-74.
8. Green DM, Finklestein JZ, Norkoul P, D'Angio J. Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine. A report of the National Wilms' Tumor Study. Cancer 1988;62:270-3.
9. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, et al. The Intergroup Rhabdomyosarcoma Study II. Cancer 1993;71:1904-22.
10. Gehan E, Lawrence W, Hays D, Maurer HM. Pre-treatment staging system for pediatric rhabdomyosarcoma patients [abstract]. Proc Am Soc Clin Oncol 1988;7:255.
11. Rollins BJ. Hepatic veno-occlusive disease. Am J Med 1986;81:297-306.
12. Zimmerman HJ. Hepatotoxic effects of oncotherapeutic agents, In: Popper H, Shaffer F, editors. Progress in liver disease. Philadelphia: Grune & Stratton, 1986:117-41.
13. Callihan T, Webber B, Hayes FA, Etcubanas E, Green A. Chemotherapy-induced hepatic veno-occlusive disease (VOD) [abstract]. Proc Am Soc Clin Oncol 1983;2:76.
14. Kanwar VS, Alburquerque MC, Ribeiro RC, Kauffman WM, Furman WC. Veno-occlusive disease of the liver after chemotherapy for rhabdomyosarcoma. A case report with a review of the literature. Med Pediatr Oncol 1995;24:334-40.
15. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JC, Banaji M, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation. A cohort study of 355 patients. Ann Intern Med 1993;118:255-67.
16. Tamimiau JAJM, Delemarre JM, de Kraker J. Veno-occlusive disease and peliosis, vascular lesions of the liver in children following chemotherapy [abstract]. Proc Int Soc Pediatr Oncol 1985;16:77.
17. Bjork O, Eklof O, Willi V, Ahstrom C. Veno-occlusive disease and peliosis of the liver complicating the course of Wilms' Tumor. Acta Radiol Diagn 1985;26:589-97.
18. Cassady JR, Carabell SC, Jaffe N. Chemotherapy-irradiated related hepatic dysfunction in patients with Wilms' tumor. Front Radiat Ther Oncol 1979;13:147-70.
19. Altai M, Huguet F, Rubie H, Charlet JP, Schlaifer D, Huynh A, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin. A prospective randomized trial. Blood 1992;79:1-7.
20. Baglin TP, Harper P, Marcus RE. Venoocclusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). Bone Marrow Transplant 1990;5:439-41.
21. Bearman S, Shuhart MC, Hinds MS, McDonald GB. Recombinant tissue plasminogen activator for the treatment of established severe hepatic venooclusive disease of the liver after bone marrow transplantation. Blood 1992;80:2458-62.